FDA-Drug2020-01-29Class II
Preferred Pharmaceuticals, Inc, Ranitidine Tablets, 300 mg, Rx Only, a) 14 count bottles (NDC: 68788-6382-1), b) 30 count bottles (NDC: 68788-6382-3), c) 90 count bottles (NDC: 68788-6382-9), d) 100 count bottles (NDC: 68788-6382-0)
Preferred Pharmaceuticals, Inc
Hazard
CGMP Deviations: Presence of NDMA impurity detected in product.
Sold states
Distribution to physicians in the following states: AL, AZ, CA, FL, GA, IN, and SC
Affected count
39,172 tablets
Manufactured in
1250 N Lakeview Ave Ste O, Anaheim, CA, United States
Products
Preferred Pharmaceuticals, Inc, Ranitidine Tablets, 300 mg, Rx Only, a) 14 count bottles (NDC: 68788-6382-1), b) 30 count bottles (NDC: 68788-6382-3), c) 90 count bottles (NDC: 68788-6382-9), d) 100 count bottles (NDC: 68788-6382-0)
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0797-2020Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief